Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Garofalo
Efficacy of and Resistance to Anti-Igf-1r Therapies in Ewing's Sarcoma Is Dependent on Insulin Receptor Signaling
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis
PLoS ONE
Multidisciplinary
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination With Anti-Igf Signaling Agents
Clinical Cancer Research
Cancer Research
Oncology
Figure 1: IGF-1R and EGFR Signaling Pathway.
Vitamin D Inhibits CEACAM1 to Promote Insulin/Igf-I Receptor Signaling Without Compromising Anti-Proliferative Action
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Picropodophyllin Inhibits the Growth of Ewing's Sarcoma Cells Through the Insulin-Like Growth Factor-1 Receptor/Akt Signaling Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Icaritin, a Novel FASN Inhibitor, Exerts Anti-Melanoma Activities Through IGF-1R/STAT3 Signaling
Oncotarget
Oncology
Anti-Tumor Effect of the Insulin-Like Growth Factor-1 Receptor (IGF-1R) on Human Pancreatic Cancer Cells in Both in Vitro and in Vivo Studies
Suizo
High Fat Diet Induced Insulin Resistance and Glucose Intolerance Are Gender-Specific in IGF-1R Heterozygous Mice
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
